Elanco's Credelio Quattro Outperforms Rivals in Rapid Tick Kill — Elanco Animal Health Incorporated

Event summary

Elanco's Credelio Quattro kills black-legged ticks faster than competitors, achieving significant reduction within 8 hours.
Lotilaner, the active ingredient in Credelio Quattro, kills lone star ticks in just 12 hours, maintaining this speed throughout the dosing interval.
Study results published in Parasites & Vectors show Credelio Quattro maintains its 8-hour speed of kill on Day 28, unlike competitors whose performance declined.
Credelio Quattro has FDA approval for preventing Lyme disease in dogs by killing black-legged ticks.

The big picture

Elanco's Credelio Quattro represents a strategic advancement in the parasiticides market, addressing the critical need for rapid tick kill to prevent disease transmission. The product's superior performance against key competitors positions Elanco favorably in an industry where speed of efficacy is increasingly prioritized by veterinarians and pet owners. As tick populations expand geographically and tick-borne diseases pose greater risks, Elanco's innovation could drive market share gains and reinforce its leadership in animal health.

What we're watching

Market Differentiation: Whether Elanco can sustain its competitive edge in the parasiticides market with Credelio Quattro's superior speed of kill.
Regulatory Approvals: The pace at which Elanco secures additional FDA approvals for Credelio Quattro, expanding its indications and market reach.
Consumer Adoption: How quickly veterinarians and pet owners adopt Credelio Quattro given its proven efficacy against multiple tick species.